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NW7 1AA, United Kingdom.As a member of the dynamin superfamily human guanylate-binding protein 1 (hGBP1) binds and
hydrolyses GTP thereby undergoing structural changes which lead to self-assembly of the protein.
Here, we employ the reactivity of hGBP1 with a cysteine reactive compound in order to monitor
structural changes imposed by GTP binding and hydrolysis. Positions of cysteine residues buried
between the C-terminal domain of hGBP1 and the rest of the protein are identiﬁed which report
a large change of accessibility by the compound after addition of GTP. Our results indicate that
nucleotide hydrolysis induces a domain movement in hGBP1, which we suggest enables further
assembly of the protein.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The human guanylate-binding protein 1 (hGBP1) belongs to a
family of GTPases, which are synthesized to high levels after treat-
ment of cells with interferons [1,2]. In this context hGBP1 was
shown to provide an antiviral effect against vesicular stomatitis
virus and encephalomyocarditis virus [3]. Furthermore, elevated lev-
els of hGBP1 were found in the cerebrospinal ﬂuid of patients with
bacterial meningitis [4]. Recently it was shown that hGBP1 inhibits
cell spreading and migration of endothelial cells through induction
of integrin alpha(4) expression [5].
Since hGBP1 may play an important role in host pathogen de-
fense it has been extensively investigated. As a member of the dyn-
amin superfamily hGBP1 shares features that are characteristic for
this family like nucleotide dependent oligomerization and self-
stimulated GTPase activity [6–8]. However, a detailed characteriza-
tion of hGBP1 on a biochemical and structural level also revealed
some features which are unique among the dynamin superfamily:
hGBP1 binds the three guanine nucleotides, GMP, GDP and GTP
with similar afﬁnity [2] and is capable to hydrolyze GTP not only
to GDP but also to GMP in consecutive steps [9–11].
hGBP1 has a molecular mass of approximately 67 kDa and
consists of a large GTPase (LG) domain at the N-terminus, a
middle domain (a-helices 7–11) and a C-terminal domainchemical Societies. Published by E
al Research, Mill Hill, Londoncomprising a-helices 12 and 13 (Fig. 1). The architecture of the
LG-domain resembles the canonical structure of the small GTPase
Ras, extended by a few loop insertions. The middle domain ex-
tends the protein by 90 Å leading to the elongated shape of
hGBP1 [8]. In the C-terminal part a-helix 12 covers the complete
length of the protein, covalently linked to the middle domain on
one end and forming non-covalent contacts to the middle and the
LG-domain (Fig. 1). Investigation by size exclusion chromatogra-
phy showed that binding of guanosine 50-[b,c-imido]triphosphate
(GppNHp), a non-hydrolysable analogue of GTP, resulted in the
formation of dimers. Binding of aluminum ﬂuoride (GDP*AlFx),
which mimics the transition state of GTP hydrolysis, leads to
the formation of tetramers [12]. In the nucleotide-free as well
as in GMP and GDP bound states hGBP1 was found to be a mono-
mer. Dimer formation is established through contacts of the two
LG-domains as shown by mutational data and various crystal
structures of the LG-domain bound to different nucleotides [12].
The crystal structure of full-length protein bound to GppNHp
could not reveal further information about oligomerization of
the protein presumably due to crystal packing forces [13]. Com-
parison of the structures of the full-length protein and the LG-do-
main bound to different nucleotides and nucleotide analogues
suggests that the position of a12 and a13 is possibly changed
during GTP dependent self-assembly and GTP hydrolysis: a move-
ment of helix a40 was detected comparing the monomeric and di-
meric LG-domain structures, which is incompatible with the
position of a12/a13 seen in full-length hGBP1 and therefore
may force a12/13 into a different conformation [14].lsevier B.V. All rights reserved.
Fig. 1. Crystal structure of hGBP1 in ribbon presentation (PDB: 1dg3) with the LG-domain colored in green, the middle domain in blue and the C-terminal helices a12/13 in
red. All cysteine residues are highlighted in orange except C589 from the C-terminal CAAX motif, which is not visible in the structure.
1924 T. Vöpel et al. / FEBS Letters 583 (2009) 1923–1927A shortcoming of the crystallographic data available so far is the
absence of the middle and C-terminal domains in most structures
of the nucleotide bound forms of hGBP1. In particular, the structure
of the complex of full-length hGBP1 with GDP*AlFx, which leads to
formation of tetramers in solution, is not known. Therefore, we ad-
dress here structural changes of full-length hGBP1 induced by
binding and hydrolysis of GTP. We employ a water soluble com-
pound that reacts with sulfhydryl groups under formation of a col-
ored side product [15], thereby indicating solvent accessible
cysteine residues of hGBP1. We can clearly localize residues of
hGBP1 that become solvent exposed after addition of GTP and
we suggest a large structural change which may be responsible
for tetramer formation of hGBP1.
2. Materials and methods
2.1. Mutagenesis
The mutant termed hGBP1 Cys-5 contains the mutations C12A,
C270A, C311S, C396A, and C589S and it was generated by succes-
sive PCR reactions according to the instructions of the Quick-
Change site directed mutagenesis kit (Stratagene, USA). Using
hGBP1 Cys-5 as a template, two other mutants were generated:
The ﬁrst, termed hGBP1 Cys-6, has another cysteine less (C225S)
and the second, termed hGBP1 Cys-5 + 1, contains an additional
cysteine residue (H357C). All products of the mutagenesis reac-
tions were veriﬁed by DNA sequencing.
2.2. Protein preparation
All protein variants of hGBP1 were expressed from a pQE80L
vector (Qiagen, Germany) in Escherichia Coli strain BL21 (DE3). Pro-
tein preparations were performed as described [10]. The buffers
did not contain any DTE as it would interfere with the DTNB reac-
tion. Concentrations were determined by the protein absorbance at
276 nm (e276 (hGBP1) = 44 500 M1 cm1) in buffer containing
20 mM potassium phosphate, 6 M guanidinium hydrochloride,
pH 6.5 according to the method described by Gill and von Hippel
[16].
2.3. DTNB reaction
The reactions of hGBP1 with the colorless 5,50-Dithio-bis(2-
nitrobenzoic acid) termed DTNB (Invitrogen, USA) and also knownas Ellman’s reagent [15] were carried out in 50 mM potassium
phosphate, 5 mM MgCl2, pH 7.4, at 25 C. In the presence of alumi-
num ﬂuoride potassium phosphate was replaced by 3-(N-Morpho-
lino)-propanesulfonic acid to avoid precipitation of aluminum
phosphate. The buffers were degassed before usage. The Ellman’s
reaction was started by mixing the protein solution at the same
time with buffer containing the Ellman’s reagent and one of the
nucleotides. The concentrations of DTNB and hGBP1 were
200 lM and 10 lM, respectively. The resulting formation of the
yellow thio-nitrobenzoate anion (TNB2) was followed by detec-
tion of its absorbance at 412 nm [15] using a Specord 200 spectral
photometer (Analytik Jena, Germany). As one cysteine reacting
with DTNB generates one molecule of TNB2- the number of reacted
cysteines was calculated from the absorption values at 412 nm
using an absorption coefﬁcient of e412 = 14 150 M1 cm1 for
TNB2 [17–18]. As the hGBP1 concentration was 10 lM in all as-
says an absorption value of 0.1415 corresponds to an equivalent
of one cysteine residue reacted with DTNB. Accordingly, the ordi-
nate scales in Fig. 2 are transformed from absorption values to cys-
teine equivalents.
2.4. GTPase activity
The GTPase activity of hGBP1 wild-type and mutants was mea-
sured as described in [7] with the exception that the measure-
ments were carried out at 25 C and at concentrations of 0.5 lM
hGBP1 and 350 lM GTP. Aliquots were taken after deﬁned incuba-
tion times and analyzed by reversed phase chromatography using
a Chromolith Performance RP-18 endcapped column (Merck, Ger-
many) as described [7].
3. Results and discussion
hGBP1 belongs to the dynamin superfamily of large GTP-bind-
ing proteins and as such it shows nucleotide dependent self-asso-
ciation [8]. While it is monomer in the nucleotide-free form as well
as in the GMP and GDP bound states formation of dimers is ob-
served after binding of GppNHp, a non-hydrolysable analogue of
GTP. Moreover, in the presence of GDP and aluminum ﬂuoride
hGBP1 forms tetramer assemblies [12]. The crystal structures of
the LG-domain of hGBP1 solved in complex with the nucleotides
mentioned above suggest structural changes that may lead to the
formation of dimers and tetramers, respectively [14]. In this work,
we approach the investigation of structural changes in full-length
Fig. 2. Reaction of hGBP1 (10 lM) with DTNB (200 lM). The time course of the
absorption at 412 nm was recorded and scaled as equivalents of reacted cysteine
residues (see Section 2). (A) hGBP1 wild-type and hGBP1 Cys-5 in the presence of
250 lM GMP or 3.4 mM GTP. (B) hGBP1 Cys-5 + 1 in the presence of 250 lM GMP,
250 lM GppNHp, 250 lM GDP*AlFx or 3.4 mM GTP.
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are interested in potential rearrangements of the three domains of
hGBP1, which are shown in Fig. 1.
In order to identify structural changes of hGBP1 in dependence
of the nucleotide bound we employed Ellman‘s reagent. This com-
pound, DTNB = 5,50-dithio-bis(2-nitrobenzoic acid), reacts with
cysteine residues that are accessible at the surface of the protein.
By concomitant formation of stoichiometric amounts of the yellow
thio-nitrobenzoate anion (TNB2) the number of reactive cysteine
residues can be deﬁned and the time course of their oxidation
can be monitored.Table 1
Accessible surface area (ASA) calculated for selected residues of hGBP1 (PDB: 1dg3).
hGBP1 residue Wild-type ASA (Å2) Cys-5 ASA
Cys 12 14.1
Cys 82 0.0 0.0
Cys 225 7.6 7.6
Cys 235 2.3 2.3
Cys 270 12.1
Cys 311 7.3
Cys 396 18.5
Cys 407 0.0 0.0
His 357 0.5In a ﬁrst step solvent accessible cysteine residues in hGBP1
were identiﬁed in the crystal structure [PDB: 1dg3]. To this end,
the accessible surface area (ASA) [19] of the protein was calculated
(Table 1) using the software Surface Racer and a probe with a ra-
dius of 1.4 Å [20]. The results of the calculation show that out of
nine cysteines located in hGBP1 (Fig. 1) residues C12, C225, C270
(LG-domain), C311 (middle domain) and C396 (helix 12) are at
least partially solvent exposed. None of these cysteine residues is
located directly in the LG-domain dimer interface. Residue C589
is not included in the calculation because it is not resolved in the
crystal structure. However, this residue is part of the C-terminal
CAAX motif known to be farnesylated and therefore this cysteine
is likely to be completely solvent accessible.
The computational results on direct accessibility of cysteine res-
idues by the solvent were checked by reaction with DTNB. In the
hGBP1*GMP complex, representing a monomeric state of hGBP1,
two cysteines are reacting instantaneously while another two res-
idues show a reaction within the ﬁrst 5–15 min of incubation with
DTNB as indicated by the fast rise of the absorption value of the
yellow product at 412 nm (Fig. 2A). Possible candidates are C589
and C396 and C12 and C270, respectively, as judged from their sol-
vent accessibility (table 1). Within the next 30 min another cys-
teine reacts slowly with DTNB, most likely C311 as described
below. On a time scale longer than 40 min the absorption increases
steadily but very slowly indicating the reaction of DTNB with the
other four cysteine residues of hGBP1, which are difﬁcult to access
from the solvent. The kinetics and the amplitudes (i.e. the number
of reacted cysteine residues) shown in Fig. 2A were highly repro-
ducible in more than three experiments in the presence of GMP.
Moreover, most similar DTNB reactivity data are obtained in the
presence of GDP and in the absence of any nucleotide (data not
shown) indicating the same accessibility of the cysteines by DTNB
for all monomer forms of hGBP1.
In a next step, we attempted to eliminate all cysteines that are
surface exposed because they are most likely not indicative for glo-
bal structural rearrangements or changes of the protein domains.
Therefore, a mutant of hGBP1 was generated, termed Cys-5, where
the four cysteine residues mentioned above were replaced, and in
addition C311, as one of the two residues with an accessible sur-
face area close to 7 Å2 (table 1) was included as the ﬁfth mutation,
i.e. C12A, C270A, C311S, C396A and C589S. Residues C311 and
C589 were replaced by serine rather than alanine residues as their
sulfhydryl groups are only surrounded by water molecules or
hydrophilic side chains while the other cysteine residues are close
to hydrophobic side chains. Measurements of the catalytic activity
of hGBP1 Cys-5 show that the GTPase activity is only slightly in-
creased (1.5-fold) compared to the wild-type (Table 2). We have
also analyzed hGBP1 Cys-5 as well as the other mutants used in
this study for their ability to hydrolyze GDP. All mutants show a
more than 1000-fold smaller catalytic activity towards GDP than
towards GTP, similar to hGBP1 wild-type. Hence, the mutations
in hGBP1 Cys-5 do not disturb the catalytic activity of hGBP1.(Å2) Cys-5 + 1 ASA (Å2) Cys-6 ASA (Å2)
0.0 0.0
7.6
2.3 2.3
0.0 0.0
0.5
Table 2
Speciﬁc GTPase activity measured with 0.5 lM hGBP1 and 350 lM GTP at 25 C.
hGBP1 Hydrolysis (min1)
Wild-type 22.8
Cys-5 33.9
Cys-5 + 1 35.1
Cys-6 55.8
Table 3
Difference in the number of cysteine residues of hGBP1 reacted with DTNB after
40 min in the presence of GTP, GppNHp and GDP*AlFx, compared to the presence of
GMP.
hGBP1 D(GTP-GMP) D(GppNHp-GMP) D(GDP*AlFx-GMP)
Wild-type 0.9 0.2 0.7
Cys-5 0.9 0.3 0.8
Cys-5 + 1 1.8 0.8 1.7
Cys-6 0.07 0.07 0.05
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a small and slow increase of absorption (Fig. 2A bottom, continu-
ous curve). Notably, a difference of ﬁve cysteine equivalents is ob-
served compared to wild-type. We conclude that the ﬁve cysteine
residues selected for mutation are responsible for the fast reaction
of hGBP1 wild-type with DTNB described in the previous para-
graph, whereas the remaining C82, C225, C235 and C407 are not
easily accessible by DTNB and react very slowly. Thus, from the
two residues with a similar accessible surface area, close to 7 Å2,
C311 seems to react faster with DTNB than C225, at least when
hGBP1 is monomer. The change in reactivity of C225 in different
nucleotide bound states is addressed below.
In order to detect structural changes associated with GTP in-
duced self-assembly and GTP hydrolysis, we have measured the
reactivity of hGBP1 with DTNB in the presence of GTP. In different
experiments a 340-fold excess of GTP over hGBP1 and a 1500-fold
excess was added, where the latter concentration ensures GTP toFig. 3. (A) Surface presentation of the hGBP1 full length crystal structure (PDB: 1dg3),
domain a12/13 in red. (B) The same model as in (A) without a12/13 in order to visualize
the same orientation as in Fig. 1 and the same color code is used for the three protein dbe present throughout the full time course recorded. The kinetics
of TNB2- formation is similar to the experiment with GMP bound
hGBP1 but, intriguingly, there is 1 equiv. of cysteine in addition
taking part in the fast phase of the reaction (Fig. 2A). Also at the
low background of DTNB reactivity using hGBP1 Cys-5 one addi-
tional equivalent of cysteine reacts rapidly with DTNB in the pres-
ence of GTP (Fig. 2A). Thus, GTP binding and hydrolysis lead to a
structural change in hGBP1, which dramatically changes the sol-
vent accessibility of one of the cysteines. Similar results are ob-
tained in the presence of 3.4 mM and 15 mM GTP, but the slope
of the slow phase is slightly smaller at the lower GTP concentra-
tion, since most of the GTP is turned over after 10 min (Supplemen-
tary Fig. 1). From the cysteine residues remaining in the Cys-5
mutant, C225 is the most likely candidate to be changed in acces-
sibility as it is part of the helix a40 located between the LG-domain
and the C-terminal helices a12/13 (Fig. 1). The crystal structures ofthe LG-domain is colored in green, the middle domain in blue, and the C-terminal
the accessibility of residues 225 and 357 (highlighted in yellow). Both models are in
omains.
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which is in contact with a12/13 in hGBP1 full length [14]. A similar
shift of a4´ in the full-length protein would lead to a sterical clash
with a12/13 and therefore the LG-domain and a12/13 might be
moved away from each other in the course of GTP hydrolysis. To
conﬁrm that the observed change in DTNB reactivity is indeed
caused by a change in solvent accessibility of cysteine 225, we gen-
erated the mutant hGBP1 Cys-6 with C225S in addition to the
mutations in hGBP1 Cys-5. The results for the DTNB reaction in
the presence of GMP and GTP show no difference at all (Table 3
and Supplementary Fig. 1) clearly demonstrating that position
225 is responsible for the difference of one cysteine equivalent be-
tween the GMP and GTP bound states described above for wild-
type and Cys-5. Interestingly, the GTPase activity of hGBP1 Cys-6
(Table 2) is 2.5-fold higher than the activity of hGBP1 wild-type
possibly indicating that mutation at position 225 close to the
a12/13 contact of the LG-domain leads to a slightly changed struc-
ture/function relationship.
In order to strengthen our hypothesis that the subdomain a12/
13 changes its position relative to the other two domains of hGBP1
we introduced an additional cysteine residue in hGBP1 Cys-5 at po-
sition 357. This residue is buried between a12/13 and the middle
domain and might become solvent accessible upon potential
detachment of a12/13 from the rest of the protein (Fig. 3). In fact,
the reaction time course of this mutant, hGBP1 Cys-5 + 1, with
DTNB shows a difference of two cysteine equivalents when GTP
is present in comparison to GMP (Fig. 2B). As two residues located
in two independent domains, i.e. C225 and C357, become accessi-
ble we take this as an indication for a structural shift of a12/13 rel-
ative to the other two domains of the protein rather than only a
local conformational change.
The cleft generated between the protein domains seems to be
large enough to accommodate a DTNB molecule. Intriguingly, the
DTNB reactivity of hGBP1 wild-type and cysteine mutants in the
presence of GDP*AlFx, known to induce tetramer formation of
hGBP1, is similar to the reactivity observed when GTP is present
(Fig. 2B and Table 3). The kinetics is slightly altered but, the same
number of cysteines has reacted after 40 min. In contrast, in the
presence of GppNHp, where hGBP1 forms dimers but does not cat-
alyze hydrolysis, the increase in DTNB reactivity is only small. This
difference between the two triphosphate analogues may indicate
that the complete rearrangement of a12/13 depends on GTP
hydrolysis rather than only binding and that this rearrangement
may facilitate tetramer formation of hGBP1. This hypothesis is fur-
ther supported by the crystal structure of hGBP1 in complex with
GppNHp [13] (PDB: 1f5n), where a shift of the helices a12/13 is
not observed.
In summary, our observations revealed cysteine residues at
positions 225 and 357 and their nucleotide dependent reactivity
with DTNB to be adequate reporters of intramolecular structural
changes of hGBP1 upon GTP hydrolysis. Taking this together with
the observation of the nucleotide dependent shift of a40 in the
LG-domain which is connected to the C-terminal domain a12/13
[14] we suggest that a12/13 is moved somewhat outwards thereby
opening a cleft between a12/13 and the rest of the protein. We
propose, that this movement facilitates formation of hGBP1 tetra-
mers, probably by uncovering a second interaction site for self-
assembly either on the middle domain or the C-terminal helices
a12/13. In addition, we have generated mutants of hGBP1, Cys-5
or Cys-6, with all easily accessible cysteine residues on or near
the surface of the protein changed by mutation and with hardly
perturbed biochemical characteristics. These mutants render a
starting point for introducing cysteine residues suitable for speciﬁc
attachment of ﬂuorescence dyes or paramagnetic spin labels. Posi-
tions can be selected which are located in different domains of theprotein at distances appropriate for FRET or EPR spectroscopy.
These methods will enable us to monitor both, changes of dis-
tances between domains of hGBP1 and their dynamics, at high
resolution.
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